Abstract
The grey-lethal mouse (gl/gl) mutant most closely resembles the severe human malignant autosomal recessive OSTM1-dependent form of osteopetrosis that it has been described to be associated with neurological abnormalities. For this reason, we have analyzed the brain lipid composition (gangliosides, neutral glycosphingolipids, phospholipids and cholesterol), from gl/gl mice at different ages of development and compared with wild type mice. Both cholesterol and glycerophospholipid content and pattern in the gl/gl and control mice were very similar. In contrast, significant differences were observed in the content of several sphingolipids. Higher amount of the monosialogangliosides GM2 and GM3, and lower content of sphingomyelin, sulfatide and galactosylceramide were observed in the gl/gl brain with respect to controls. The low content of sphingomyelin, sulfatide and galactosylceramide is consistent with the immunohistochemical results showing that in the grey-lethal brain significant depletion and disorganization of the myelinated fibres is present, thus supporting the hypothesis that loss of function of the OSTM1 causes neuronal impairment and myelin deficit.
Similar content being viewed by others
Abbreviations
- gl/gl :
-
grey-lethal
- ARO:
-
Autosomal Recessive Osteopetrosis
- OSTM1:
-
osteopetrosis associated transmembrane protein 1
- HSC:
-
haematopoietic stem cells
- HPTLC:
-
high-performance thin layer chromatography
References
Tolar, J., Teitelbaum, S.L., Orchard, P.J.: Osteopetrosis. N. Engl. J. Med. 351, 2839–2849 (2004). doi:10.1056/NEJMra040952
Sobacchi, C., Frattini, A., Guerrini, M.M., Abinun, M., Pangrazio, A., Susani, L., et al.: Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL. Nat. Genet. 39, 960–962 (2007). doi:10.1038/ng2076
Frattini, A., Orchard, P.J., Sobacchi, C., Giliani, S., Abinun, M., Mattsson, J.P., et al.: Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat. Genet. 25, 343–346 (2000). doi:10.1038/77131
Kornak, U., Schulz, A., Friedrich, W., Uhlhaas, S., Kremens, B., Voit, T., et al.: Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis. Hum. Mol. Genet. 9, 2059–2063 (2000). doi:10.1093/hmg/9.13.2059
Scimeca, J.C., Quincey, D., Parrinello, H., Romatet, D., Grosgeorge, J., Gaudray, P., et al.: Novel mutations in the TCIRG1 gene encoding the a3 subunit of the vacuolar proton pump in patients affected by infantile malignant osteopetrosis. Hum. Mutat. 21, 151–157 (2003). doi:10.1002/humu.10165
Frattini, A., Pangrazio, A., Susani, L., Sobacchi, C., Mirolo, M., Abinun, M., et al.: Chloride schannel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis. J. Bone Miner. Res. 18, 1740–1747 (2003). doi:10.1359/jbmr.2003.18.10.1740
Kornak, U., Kasper, D., Bosl, M.R., Kaiser, E., Schweizer, M., Schulz, A., et al.: Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 104, 205–215 (2001). doi:10.1016/S0092-8674(01)00206-9
Cleiren, E., Benichou, O., Van Hul, E., Gram, J., Bollerslev, J., Singer, F.R., et al.: Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene. Hum. Mol. Genet. 10, 2861–2867 (2001). doi:10.1093/hmg/10.25.2861
Lange, P.F., Wartosch, L., Jentsch, T.J., Fuhrmann, J.C.: ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function. Nature 440, 220–223 (2006). doi:10.1038/nature04535
Jentsch, T.J.: Chloride and the endosomal-lysosomal pathway: emerging roles of CLC chloride transporters. J. Physiol. 578, 633–640 (2007). doi:10.1113/jphysiol.2006.124719
Chalhoub, N., Benachenhou, N., Rajapurohitam, V., Pata, M., Ferron, M., Frattini, A., et al.: Grey-lethal mutation induces severe malignant autosomal recessive osteopetrosis in mouse and human. Nat. Med. 9, 399–406 (2003). doi:10.1038/nm842
Quarello, P., Forni, M., Barberis, L., Defilippi, C., Campagnoli, M.F., Silvestro, L., et al.: Severe malignant osteopetrosis caused by a GL gene mutation. J. Bone Miner. Res. 19, 1194–1199 (2004). doi:10.1359/JBMR.040407
Ramirez, A., Faupel, J., Goebel, I., Stiller, A., Beyer, S., Stockle, C., et al.: Identification of a novel mutation in the coding region of the grey-lethal gene OSTM1 in human malignant infantile osteopetrosis. Hum. Mutat. 23, 471–476 (2004). doi:10.1002/humu.20028
Pangrazio, A., Poliani, P.L., Megarbane, A., Lefranc, G., Lanino, E., Di Rocco, M., et al.: Mutations in OSTM1 (grey lethal) define a particularly severe form of autosomal recessive osteopetrosis with neural involvement. J. Bone Miner. Res. 21, 1098–1105 (2006). doi:10.1359/jbmr.060403
Gerritsen, E.J., Vossen, J.M., Fasth, A., Friedrich, W., Morgan, G., Padmos, A., et al.: Bone marrow transplantation for autosomal recessive osteopetrosis. A report from the Working Party on Inborn Errors of the European Bone Marrow Transplantation Group. J. Pediatr. 125, 896–902 (1994). doi:10.1016/S0022-3476(05)82004-9
Driessen, G.J., Gerritsen, E.J., Fischer, A., Fasth, A., Hop, W.C., Veys, P., et al.: Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report. Bone Marrow Transplant. 32, 657–663 (2003). doi:10.1038/sj.bmt.1704194
Feigin, M.E., Malbon, C.C.: OSTM1 regulates beta-catenin/Lef1 interaction and is required for Wnt/beta-catenin signaling. Cell. Signal. 20, 949–957 (2008). doi:10.1016/j.cellsig.2008.01.009
Ghidoni, R., Sonnino, S., Masserini, M., Orlando, P., Tettamanti, G.: Specific tritium labeling of gangliosides at the 3-position of sphingosines. J. Lipid Res. 22, 1286–1295 (1981)
Negroni, E., Chigorno, V., Tettamanti, G., Sonnino, S.: Evaluation of the efficiency of an assay procedure for gangliosides in human serum. Glycoconj. J. 13, 347–352 (1996). doi:10.1007/BF00731466
Prinetti, A., Chigorno, V., Prioni, S., Loberto, N., Marano, N., Tettamanti, G., et al.: Changes in the lipid turnover, composition, and organization, as sphingolipid-enriched membrane domains, in rat cerebellar granule cells developing in vitro. J. Biol. Chem. 276, 21136–21145 (2001). doi:10.1074/jbc.M010666200
Riboni, L., Bassi, R., Sonnino, S., Tettamanti, G.: Formation of free sphingosine and ceramide from exogenous ganglioside GM1 by cerebellar granule cells in culture. FEBS Lett. 300, 188–192 (1992). doi:10.1016/0014-5793(92)80193-K
Riboni, L., Prinetti, A., Pitto, M., Tettamanti, G.: Patterns of endogenous gangliosides and metabolic processing of exogenous gangliosides in cerebellar granule cells during differentiation in culture. Neurochem. Res. 15, 1175–1183 (1990). doi:10.1007/BF01208577
Svennerholm, L.: Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method. Biochim. Biophys. Acta 24, 604–611 (1957). doi:10.1016/0006-3002(57)90254-8
Bartlett, G.R.: Phosphorus assay in column chromatography. J. Biol. Chem. 234, 466–468 (1959)
Kean, E.L.: Separation of gluco- and galactocerebrosides by means of borate thin-layer chromatography. J. Lipid Res. 7, 449–452 (1966)
Prinetti, A., Chigorno, V., Tettamanti, G., Sonnino, S.: Sphingolipid-enriched membrane domains from rat cerebellar granule cells differentiated in culture. A compositional study. J. Biol. Chem. 275, 11658–11665 (2000). doi:10.1074/jbc.275.16.11658
Vaskovsky, V.E., Kostetsky, E.Y.: Modified spray for the detection of phospholipids on thin-layer chromatograms. J. Lipid Res. 9, 396 (1968)
Partridge, S.M.: Filter-paper partition chromatography of sugars: 1. General description and application to the qualitative analysis of sugars in apple juice, egg white and foetal blood of sheep. with a note by R. G. Westall. Biochem. J. 42, 238–250 (1948)
Schwimmer, S., Bevenue, A.: Reagent for differentiation of 1,4- and 1,6-linked glucosaccharides. Science 123, 543–544 (1956). doi:10.1126/science.123.3196.543
Banny, T.M., Clark, G.: The new domestic cresyl echt violet. Stain Technol. 25, 195–196 (1950)
Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J.: Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265–275 (1951)
Gruneberg, H.: Grey-lethal, a new mutation in the house mouse. J. Hered. 27, 105–109 (1936)
Walker, D.G.: Spleen cells transmit osteopetrosis in mice. Science 190, 785–787 (1975). doi:10.1126/science.1198094
Matthieu, J.M., Widmer, S., Herschkowitz, N.: Biochemical changes in mouse brain composition during myelination. Brain Res. 55, 391–402 (1973). doi:10.1016/0006-8993(73)90304-1
Chen, C.S., Patterson, M.C., Wheatley, C.L., O’Brien, J.F., Pagano, R.E.: Broad screening test for sphingolipid-storage diseases. Lancet 354, 901–905 (1999). doi:10.1016/S0140-6736(98)10034-X
Chigorno, V., Tettamanti, G., Sonnino, S.: Metabolic processing of gangliosides by normal and Salla human fibroblasts in culture. A study performed by administering radioactive GM3 ganglioside. J. Biol. Chem. 271, 21738–21744 (1996). doi:10.1074/jbc.271.36.21738
Utsumi, K., Tsuji, A., Kase, R., Tanaka, A., Tanaka, T., Uyama, E., et al.: Western blotting analysis of the beta-hexosaminidase alpha- and beta-subunits in cultured fibroblasts from cases of various forms of GM2 gangliosidosis. Acta Neurol. Scand. 105, 427–430 (2002). doi:10.1034/j.1600-0404.2002.01097.x
Gieselmann, V.: Lysosomal storage diseases. Biochim. Biophys. Acta 1270, 103–136 (1995)
Huwiler, A., Kolter, T., Pfeilschifter, J., Sandhoff, K.: Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim. Biophys. Acta 1485, 63–99 (2000)
Igisu, H., Suzuki, K.: Progressive accumulation of toxic metabolite in a genetic leukodystrophy. Science 224, 753–755 (1984). doi:10.1126/science.6719111
Suzuki, K.: Twenty five years of the “psychosine hypothesis”: a personal perspective of its history and present status. Neurochem. Res. 23, 251–259 (1998). doi:10.1023/A:1022436928925
Sonnino, S., Mauri, L., Chigorno, V., Prinetti, A.: Gangliosides as components of lipid membrane domains. Glycobiology 17, 1R–13R (2007). doi:10.1093/glycob/cwl052
Reddy, A., Caler, E.V., Andrews, N.W.: Plasma membrane repair is mediated by Ca(2+)-regulated exocytosis of lysosomes. Cell 106, 157–169 (2001). doi:10.1016/S0092-8674(01)00421-4
Allinquant, B., Hantraye, P., Mailleux, P., Moya, K., Bouillot, C., Prochiantz, A.: Downregulation of amyloid precursor protein inhibits neurite outgrowth in vitro. J. Cell Biol. 128, 919–927 (1995). doi:10.1083/jcb.128.5.919
Ikezu, T., Trapp, B.D., Song, K.S., Schlegel, A., Lisanti, M.P., Okamoto, T.: Caveolae, plasma membrane microdomains for alpha-secretase-mediated processing of the amyloid precursor protein. J. Biol. Chem. 273, 10485–10495 (1998). doi:10.1074/jbc.273.17.10485
Simons, M., Keller, P., De Strooper, B., Beyreuther, K., Dotti, C.G., Simons, K.: Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. U. S. A. 95, 6460–6464 (1998). doi:10.1073/pnas.95.11.6460
Choo-Smith, L.P., Surewicz, W.K.: The interaction between Alzheimer amyloid beta(1–40) peptide and ganglioside GM1-containing membranes. FEBS Lett. 402, 95–98 (1997). doi:10.1016/S0014-5793(96)01504-9
Fortin, D.L., Troyer, M.D., Nakamura, K., Kubo, S., Anthony, M.D., Edwards, R.H.: Lipid rafts mediate the synaptic localization of alpha-synuclein. J. Neurosci. 24, 6715–6723 (2004). doi:10.1523/JNEUROSCI.1594-04.2004
Benarroch, E.E.: Lipid rafts, protein scaffolds, and neurologic disease. Neurology 69, 1635–1639 (2007). doi:10.1212/01.wnl.0000279590.22544.c3
Vey, M., Pilkuhn, S., Wille, H., Nixon, R., DeArmond, S.J., Smart, E.J., et al.: Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc. Natl. Acad. Sci. U. S. A. 93, 14945–14949 (1996). doi:10.1073/pnas.93.25.14945
Rodriguez-Lafrasse, C., Vanier, M.T.: Sphingosylphosphorylcholine in Niemann-Pick disease brain: accumulation in type A but not in type B. Neurochem. Res. 24, 199–205 (1999). doi:10.1023/A:1022501702403
Yu, R.K., Bieberich, E., Xia, T., Zeng, G.: Regulation of ganglioside biosynthesis in the nervous system. J. Lipid Res. 45, 783–793 (2004). doi:10.1194/jlr.R300020-JLR200
Maxzud, M.K., Daniotti, J.L., Maccioni, H.J.: Functional coupling of glycosyl transfer steps for synthesis of gangliosides in Golgi membranes from neural retina cells. J. Biol. Chem. 270, 20207–20214 (1995). doi:10.1074/jbc.270.34.20207
Maccioni, H.J.: Glycosylation of glycolipids in the Golgi complex. J. Neurochem. 103(Suppl 1), 81–90 (2007). doi:10.1111/j.1471-4159.2007.04717.x
Acknowledgements
This work was supported by University of Milan (FIRST to S.S.), CARIPLO Foundation (to S.S.) and by Mitzutani Foundation for Glycoscience (to A.P.).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Prinetti, A., Rocchetta, F., Costantino, E. et al. Brain lipid composition in grey-lethal mutant mouse characterized by severe malignant osteopetrosis. Glycoconj J 26, 623–633 (2009). https://doi.org/10.1007/s10719-008-9179-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10719-008-9179-8